Association of autoimmune active chronic hepatitis with HL-A1,8.
about
HLA and cell-mediated immunity in HBsAg negative chronic active hepatitisGenetic associations between myasthenia gravis and the HL-A systemHLA in eczema and hay feverMyasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravisAlteration in suppressor cell activity in chronic active hepatitis.Diseases associated with specific HL-A antigens.Recent advances in the study of the epidemiology of hepatitis B.Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver diseaseAutoimmune chronic active hepatitis in a familyChronic active hepatitis.Immunological aspects of liver disease.Distribution of HLA histocompatibility antigens, ABO blood groups and Rh antigens in alcoholic liver disease.Chronic hepatitis.Genetic analysis of patients with chronic active hepatitisLiver disease and the e antigen in HBsAg carriers with chronic renal failure.Association of primary sclerosing cholangitis with HLA-B8.Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trialImmunological changes in liver disease.Immunological studies in cystic fibrosis.Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.The concept of autoimmune liver disease.Hepatitis B antigen (HBAg) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAgAn unusual form of autoimmune hepatitis in young Somalian men.Transforming growth factor-beta1, Th1 responses, and autoimmune liver disease.Jejunal villous changes associated with farmer's lung.Historical reflections on autoimmune hepatitis.Auto-immune chronic active hepatitis: a specific entity? The negative argument.Auto-immune (lupoid) hepatitis: an entity in the spectrum of chronic active liver disease.Hyperbilirubinemic and cholestatic syndromes. New concepts aiding recognition and management.Characterization of factor VIII antibodies.Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis.The role of immunological mechanisms in acute and chronic hepatitis.Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells.Genetically determined immune hyperreactivity in human liver diseaseRecent developments in autoimmune liver diseases.Measles virus specific precipitins in sera from patients with chronic active hepatitis.Human leukocyte antigen (HLA) in Korean patients with autoimmune thyroid diseases.Autoimmune hepatitis: 50 Years of (slow) progress.Dermatitis herpetiformis and leiomyomas with HLA-B8, a marker of immune diseases.Association of HL-A 5 and immune responsiveness in vitro to streptococcal antigens.
P2860
Q24541422-8976A6CF-9179-44D3-AF36-EA592B55F10CQ24561525-95A57DD4-DC57-40CB-89FE-365FEBDE3622Q24678605-AAA6CEEC-AF82-47CF-B66D-52BDCC509E80Q24680629-309A510C-1C5A-4330-A4C7-970A6C750E65Q33969656-A1A0631F-5C8A-4C8C-A9B2-11365C35BEF4Q33989584-25B7CE6F-BCB7-4546-ADCF-8AA231668BE5Q34086880-187FA5A8-6FFD-4088-81AB-3C71AF3A99EFQ34210556-4F636865-D467-43DC-AF79-61EBD1B1D80CQ34393570-F077A63A-EA34-4327-AB66-C1E3791B70BAQ34460416-AF6D3379-BDEC-434C-9467-BB2DCF6B99B2Q34460439-9AF54D67-7219-4401-8B15-2DB66DE0ADB5Q34475348-A1E01F12-8957-4AD1-AB36-F489F24EA17DQ34476917-02A8A7FC-1308-405F-B8A6-635E7B54AA00Q34480896-27FC1260-E277-4521-83BA-77C67CA0F96DQ34494035-A0448ADE-C099-481D-A208-0DF0EF6C1986Q34495665-A992490B-9EAF-4808-8F3A-0E0EF90182C7Q34498312-9BEE5569-9A5D-4CA5-9080-B889D4AA4223Q34983064-34AD160C-4DC6-44B0-B401-EFFF0CA7D89DQ34986613-BBFF1375-9B58-493C-8646-091B1A5C65C8Q35126088-5E6E9574-B062-4FFE-98CD-DF856E280CD9Q35655982-411BDD9D-E7DA-4D4E-95A3-3378CC66E48DQ35957606-6BAD7ACB-4C74-42DC-A45A-F4E20D9282DFQ36075763-591F1580-8430-4BA0-94EC-6A9FC0431E1CQ36222175-AD6D95C1-DCA9-4610-8997-64578A515222Q36716846-4C81DBB1-0C18-42F4-BE64-9E4888DF05FCQ37182927-67C6B12E-8BD6-4E5C-8F05-1D4069132EA2Q37804844-B397B2C3-F897-423A-B4D7-B4A341706006Q37804845-074BEAD9-EF09-43C8-8849-DC43D828B8DFQ39229610-DC2AE97E-8F63-4AF3-A6FB-5DD76A4123F6Q39313666-568D280C-6FFF-4B02-867A-E8C08A91C53EQ40044046-FF551ABF-7886-4FB5-B292-A632CC218D7AQ41229423-0D06FE6E-38C8-40DD-A959-89DED9066ED8Q41265309-2E1454F2-EEE2-499D-A8CD-7275B72F11F0Q41333533-944B13D1-2D88-417C-9A76-26EA7DDB3E17Q41667301-EB75108D-79BD-466F-BDEA-DBBE337D4DC2Q41710417-DC7120F5-6EF3-4059-812F-3DE5A135E887Q41892427-C9812D96-7AB5-4A63-B70F-473AFDB3CCE2Q42365127-1E697E3A-91C4-4E0E-B45C-73FE6CAE0B19Q42771200-C9D758E4-C077-4AF7-AD2A-7FAAC921B0ADQ42940231-9F5F6699-F604-46DA-81BC-38BF58A410D6
P2860
Association of autoimmune active chronic hepatitis with HL-A1,8.
description
1972 nî lūn-bûn
@nan
1972 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Association of autoimmune active chronic hepatitis with HL-A1,8.
@ast
Association of autoimmune active chronic hepatitis with HL-A1,8.
@en
Association of autoimmune active chronic hepatitis with HL-A1,8.
@nl
type
label
Association of autoimmune active chronic hepatitis with HL-A1,8.
@ast
Association of autoimmune active chronic hepatitis with HL-A1,8.
@en
Association of autoimmune active chronic hepatitis with HL-A1,8.
@nl
prefLabel
Association of autoimmune active chronic hepatitis with HL-A1,8.
@ast
Association of autoimmune active chronic hepatitis with HL-A1,8.
@en
Association of autoimmune active chronic hepatitis with HL-A1,8.
@nl
P1433
P1476
Association of autoimmune active chronic hepatitis with HL-A1,8.
@en
P2093
I R Mackay
P J Morris
P304
P356
10.1016/S0140-6736(72)92149-6
P407
P577
1972-10-01T00:00:00Z